Table 2 Clinicopathological features of patients with CRTC3–MAML2 fusion-positive mucoepidermoid carcinoma
From: Clinicopathological significance of the CRTC3–MAML2 fusion transcript in mucoepidermoid carcinoma
Case | Age (years) | Sex | Tumor site | Tumor size (mm) | Nodal status | TNM | Clinical stage | Histological grade | Cystic component | Neural invasion | Necrosis | Mitoses (10 HPF) | Anaplasia | Treatment | Follow-up (months) | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 25 | F | Parotid | 18 × 15 | Negative | T1N0M0 | I | Low | 5% | No | No | 1 | No | Resection | 147 | NED |
2 | 27 | F | Parotid | 26 × 20 | Negative | T2N0M0 | II | Intermediate | 10% | No | No | 3 | Yes | Resection | 55 | NED |
3 | 24 | F | Hard plate | 27 × 20 | Negative | T2N0M0 | II | Low | 30% | No | No | 0 | No | Resection | 60 | NED |
4 | 47 | M | Parotid | 27 × 25 | Negative | T2N0M0 | II | Low | 60% | No | No | 0 | No | Resection | 113 | NED |
5 | 53 | M | Oral floor | 22 × 18 | Negative | T2N0M0 | II | Low | 10% | No | No | 1 | No | Resection | 28 | NED |
6 | 37 | F | Retromolar | 10 × 10 | Negative | T1N0M0 | I | Low | 5% | No | No | 0 | No | Resection | 39 | NED |
